美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

KaloBios Pharmaceuticals Inc.

2.95

0.0000

成交量：2.05万

成交额：6.05万

市值：- -

市盈率：- -

高：1.66

开：1.63

低：1.60

收：2.95

52周最高：1.66

52周最低：1.60

股本：- -

流通股本：- -

量比：- -

换手率：- -

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

KaloBios Pharmaceuticals Inc.

交易所：

- -

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.kalobios.com

邮编：

- -

电话：

- -

传真：

- -

简介：

<p>美国生物制药公司KaloBios提交IPO申请，计划筹集6000万美元，拟在纳斯达克上市，代码KBIO，Leerink Swann 是此次交易的唯一承销商。KBIO创立于2001年，截至2012年6月30日的12个月录得1800万美元的销售额。目前发行价格区间暂未披露。</p>

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/KBIO/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KBIO\",,,,,undefined,":{"symbol":"KBIO","market":"US","secType":"STK","nameCN":"KaloBios Pharmaceuticals Inc.","latestPrice":2.95,"timestamp":1501272000000,"preClose":2.95,"halted":0,"volume":20500,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":0,"latestTime":"07-28 16:00:00 EDT","open":1.63,"high":1.66,"low":1.6,"amount":60475.00000000001,"amplitude":0.020339,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"listingDate":1359608400000,"adjPreClose":2.95,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KBIO\",,,,,undefined,":{"symbol":"KBIO","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":1.66,"amplitude":0.020339,"preClose":2.95,"low":1.6,"week52Low":1.6,"pbRate":"--","week52High":1.66,"institutionHeld":0,"latestPrice":2.95,"eps":0,"divideRate":0,"volume":20500,"delay":0,"open":1.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-09-05","symbol":"KBIO","name":"KaloBios Pharmaceuticals Inc.","time":"","type":"earning","dateTimestamp":1473048000000,"reportTimeType":""}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KBIO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.kalobios.com","compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"<p>美国生物制药公司KaloBios提交IPO申请，计划筹集6000万美元，拟在纳斯达克上市，代码KBIO，Leerink Swann 是此次交易的唯一承销商。KBIO创立于2001年，截至2012年6月30日的12个月录得1800万美元的销售额。目前发行价格区间暂未披露。</p>","name":"KaloBios Pharmaceuticals Inc.","nameEN":"KaloBios Pharmaceuticals, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KBIO\",market:\"US\",,,undefined,":null}}